{
    "qwen-v2.5-14b-instruct": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "qwen-v2.5-14b-instruct",
            "response": [
                "Cetuximab (C225)",
                "Bevacizumab (Avastin)",
                "Panitumumab (Vectibix)",
                "Regorafenib (Stivarga)",
                "Trifluridine/tipiracil (Lonsurf)",
                "Irinotecan (Camptosar)",
                "Folfox (5-Fluorouracil, Leucovorin, Oxaliplatin)",
                "Folfiri (5-Fluorouracil, Leucovorin, Irinotecan)",
                "Capecitabine (Xeloda)",
                "Oxaliplatin (Eloxatin)",
                "Raltitrexed (Tomudex)",
                "Uft (Uracil/Tegafur)",
                "Tegafur (Adrucil)",
                "Leucovorin (Folotyn)",
                "Nalurapeptide (Aflibercept)",
                "Ziv-aflibercept (Zaltrap)",
                "Nab-paclitaxel (Abraxane)",
                "Ramucirumab (Cyramza)",
                "TAS-102 (Lonsurf)",
                "Fam-trastuzumab deruxtecan (Enhertu)",
                "Apatinib (Yivday)",
                "Nintedanib (Ofev)",
                "Trametinib (Mekinist)"
            ]
        }
    ],
    "phi-v4": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "phi-v4",
            "response": [
                "Bevacizumab (Avastin)",
                "Cetuximab (Erbitux)",
                "Panitumumab (Vectibix)",
                "Olaparib (Lynparza)",
                "Rucaparib (Rubraca)",
                "Niraparib (Zejula)",
                "Pembrolizumab (Keytruda)",
                "Atezolizumab (Tecentriq)",
                "Ipilimumab (Yervoy)",
                "Nivolumab (Opdivo)",
                "Regorafenib (Stivarga)",
                "Trifluridine/Tipiracil (Lonsurf)",
                "Cape Oligonucleotide (Avastin)",
                "Dabrafenib (Tafinlar)",
                "Trametinib (Mekinist)",
                "Encorafenib (Braftovi)",
                "Vemurafenib (Zelboraf)",
                "Lapatinib (Tykerb)",
                "Sorafenib (Nexavar)",
                "Sunitinib (Sutent)",
                "Everolimus (Afinitor)",
                "Temsirolimus (Torisel)",
                "Pazopanib (Votrient)",
                "Sorafenib (BAY 43-9006)"
            ]
        }
    ],
    "mistral-small-instruct-24B": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "mistral-small-instruct-24B",
            "response": [
                "5-Fluorouracil (5-FU)",
                "Capecitabine (Xeloda)",
                "Oxaliplatin (Eloxatin)",
                "Irinotecan (Camptosar)",
                "Leucovorin",
                "FOLFOX",
                "FOLFIRI",
                "Pemetrexed (Alimta)",
                "Bevacizumab (Avastin)",
                "Cetuximab (Erbitux)",
                "Panitumumab (Vectibix)",
                "Regorafenib (Stivarga)",
                "Ziv-aflibercept (Zaltrap)",
                "Ramucirumab (Cyramza)",
                "Trifluridine/Tipiracil (Lonsurf)",
                "Apatinib",
                "Nivolumab (Opdivo)",
                "Pembrolizumab (Keytruda)",
                "Durvalumab (Imfinzi)",
                "Atezolizumab (Tecentriq)",
                "Encorafenib (Braftovi)",
                "Binimetinib (Mektovi)",
                "Lenvatinib (Lenvima)",
                "Fruquintinib"
            ]
        }
    ],
    "gemma-3": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "gemma-3",
            "response": [
                "5-Fluorouracil (5-FU)",
                "Capecitabine (CAP)",
                "Oxaliplatin (OXA)",
                "Irinotecan (IRI)",
                "Bevacizumab (BEV)",
                "Cetuximab (CTX)",
                "Panitumumab (PAN)",
                "Regorafenib (REG)",
                "Zivafibine (ZIV)",
                "Trifluridine/Tipiracil (LONSURF)",
                "Ramucirumab (RAM)",
                "Folinic Acid (FA)",
                "Fluorodeoxyuridine (FdU)",
                "Leucovorin (LV)",
                "Afatinib (AFA)",
                "Encorafenib (ENC)",
                "Binimetinib (BIN)",
                "Sotorasib (SOT)",
                "Adagrasib (ADA)",
                "Famitinib (FAM)",
                "Fruquintinib (FRU)",
                "Teselimidrol (TES)",
                "TAS-117 (TAS)",
                "Onivyde (IRI-PEG)"
            ]
        }
    ],
    "gpt-4o": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "gpt-4o",
            "response": [
                "Fluorouracil (5-FU)",
                "Capecitabine (Xeloda)",
                "Oxaliplatin (Eloxatin)",
                "Irinotecan (Camptosar)",
                "Bevacizumab (Avastin)",
                "Cetuximab (Erbitux)",
                "Panitumumab (Vectibix)",
                "Regorafenib (Stivarga)",
                "Trifluridine/Tipiracil (Lonsurf)",
                "Ramucirumab (Cyramza)",
                "Ziv-aflibercept (Zaltrap)",
                "Pembrolizumab (Keytruda)",
                "Nivolumab (Opdivo)",
                "Atezolizumab (Tecentriq)",
                "Dostarlimab (Jemperli)",
                "Encorafenib (Braftovi)",
                "Binimetinib (Mektovi)",
                "Aflibercept (Zaltrap)",
                "Leucovorin (Wellcovorin)",
                "Sotorasib (Lumakras)",
                "Cetuximab and Encorafenib (Erbitux and Braftovi)",
                "Trastuzumab Deruxtecan (Enhertu)",
                "Larotrectinib (Vitrakvi)",
                "Entrectinib (Rozlytrek)"
            ]
        }
    ],
    "gpt-4o-mini": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "gpt-4o-mini",
            "response": [
                "Colorectal Cancer Prevention (CCP)",
                "Bevacizumab (Avastin)",
                "Cetuximab (Erbitux)",
                "Capecitabine (Xeloda)",
                "Oxaliplatin (Eloxatin)",
                "FOLFIRI (Leucovorin, Fluorouracil, Irinotecan)",
                "FOLFOX (Leucovorin, Fluorouracil, Oxaliplatin)",
                "Regorafenib (Stivarga)",
                "Trifluridine/tipiracil (Lonsurf)",
                "Pembrolizumab (Keytruda)",
                "Nivolumab (Opdivo)",
                "Atezolizumab (Tecentriq)",
                "Ziv-aflibercept (Zaltrap)",
                "Lapatinib (Tykerb)",
                "Ramucirumab (Cyramza)",
                "Dolastatin-10 (Dola)",
                "Sunitinib (Sutent)",
                "Sorafenib (Nexavar)",
                "Nab-paclitaxel (Abraxane)",
                "Irinotecan (Camptosar)",
                "Fluorouracil (5-FU)",
                "Leucovorin (Folinic acid)",
                "Aspirin (Acetylsalicylic acid)",
                "Metformin (Glucophage)"
            ]
        }
    ],
    "gpt-4-32k": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "gpt-4-32k",
            "response": [
                "Capecitabine (Xeloda)",
                "Cetuximab (Erbitux)",
                "Bevacizumab (Avastin)",
                "Oxaliplatin (Eloxatin)",
                "Fluorouracil (Adrucil)",
                "Irinotecan (Camptosar)",
                "Regorafenib (Stivarga)",
                "Raltitrexed (Tomudex)",
                "Panitumumab (Vectibix)",
                "Trifluridine/Tipiracil (Lonsurf)",
                "Ramucirumab (Cyramza)",
                "Nivolumab (Opdivo)",
                "Pembrolizumab (Keytruda)",
                "Ziv-aflibercept (Zaltrap)",
                "Lapatinib (Tykerb)",
                "Binimetinib (Mektovi)",
                "Encorafenib (Braftovi)",
                "Sotorasib (Lumakras)",
                "Trifluridine (Ftudaf)",
                "Tipiracil (Tirf)",
                "Encorafenib (Braftovi)",
                "Binimetinib (Mektovi)",
                "Atezolizumab (Tecentriq)",
                "Ipilimumab (Yervoy)"
            ]
        }
    ],
    "gpt-35-turbo-16k": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "gpt-35-turbo-16k",
            "response": [
                "Avastin (bevacizumab)",
                "Erbitux (cetuximab)",
                "Vectibix (panitumumab)",
                "Stivarga (regorafenib)",
                "Zaltrap (ziv-aflibercept)",
                "Lonsurf (trifluridine and tipiracil)",
                "Keytruda (pembrolizumab)",
                "Opdivo (nivolumab)",
                "Tecentriq (atezolizumab)",
                "Cyramza (ramucirumab)",
                "Lartruvo (olaratumab)",
                "Zelboraf (vemurafenib)",
                "Cotellic (cobimetinib)",
                "Mekinist (trametinib)",
                "Tafinlar (dabrafenib)",
                "Lynparza (olaparib)",
                "Braftovi (encorafenib)",
                "Mektovi (binimetinib)",
                "Retevmo (selpercatinib)",
                "Tabrecta (capmatinib)",
                "Lumakras (sotorasib)",
                "Tukysa (tucatinib)",
                "Fotivda (tivozanib)",
                "Rubraca (rucaparib)"
            ]
        }
    ],
    "o1-mini": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "o1-mini",
            "response": [
                "5-Fluorouracil (5-FU)",
                "Oxaliplatin",
                "Irinotecan",
                "Capecitabine",
                "Bevacizumab (Avastin)",
                "Cetuximab (Erbitux)",
                "Panitumumab (Vectibix)",
                "Aflibercept (Zaltrap)",
                "Regorafenib (Stivarga)",
                "Ramucirumab (Cyramza)",
                "Trifluridine/Tipiracil (Lonsurf)",
                "Pembrolizumab (Keytruda)",
                "Nivolumab (Opdivo)",
                "Encorafenib (Braftovi)",
                "Binimetinib (Mektovi)",
                "Leucovorin",
                "S-1",
                "FOLFIRI",
                "FOLFOX",
                "XELOX",
                "FOLFOXIRI",
                "FOLFIRI-Bevacizumab",
                "FOLFOX-Bevacizumab",
                "Cetuximab-Irinotecan"
            ]
        }
    ],
    "anthropic.claude-3-5-sonnet-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "anthropic.claude-3-5-sonnet-v1:0",
            "response": [
                "Fluorouracil (5-FU)",
                "Capecitabine (Xeloda)",
                "Oxaliplatin (Eloxatin)",
                "Irinotecan (Camptosar)",
                "Bevacizumab (Avastin)",
                "Cetuximab (Erbitux)",
                "Panitumumab (Vectibix)",
                "Regorafenib (Stivarga)",
                "Trifluridine/tipiracil (Lonsurf)",
                "Ramucirumab (Cyramza)",
                "Encorafenib (Braftovi)",
                "Binimetinib (Mektovi)",
                "Pembrolizumab (Keytruda)",
                "Nivolumab (Opdivo)",
                "Ipilimumab (Yervoy)",
                "Larotrectinib (Vitrakvi)",
                "Entrectinib (Rozlytrek)",
                "Dostarlimab (Jemperli)",
                "Leucovorin (Folinic acid)",
                "Levamisole"
            ]
        }
    ],
    "anthropic.claude-3-opus-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "anthropic.claude-3-opus-v1:0",
            "response": [
                "Fluorouracil (5-FU)",
                "Capecitabine (Xeloda)",
                "Irinotecan (Camptosar)",
                "Oxaliplatin (Eloxatin)",
                "Leucovorin (Folinic acid)",
                "Trifluridine/Tipiracil (Lonsurf)",
                "Bevacizumab (Avastin)",
                "Cetuximab (Erbitux)",
                "Panitumumab (Vectibix)",
                "Ramucirumab (Cyramza)",
                "Ziv-aflibercept (Zaltrap)",
                "Regorafenib (Stivarga)",
                "Pembrolizumab (Keytruda)",
                "Nivolumab (Opdivo)",
                "Ipilimumab (Yervoy)",
                "Encorafenib (Braftovi)",
                "Binimetinib (Mektovi)",
                "Dabrafenib (Tafinlar)",
                "Trametinib (Mekinist)",
                "Larotrectinib (Vitrakvi)",
                "Entrectinib (Rozlytrek)",
                "Dostarlimab-gxly (Jemperli)"
            ]
        }
    ],
    "anthropic.claude-3-sonnet-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "anthropic.claude-3-sonnet-v1:0",
            "response": [
                "Bevacizumab (Avastin)",
                "Capecitabine (Xeloda)",
                "Cetuximab (Erbitux)",
                "Irinotecan (Camptosar)",
                "Oxaliplatin (Eloxatin)",
                "Panitumumab (Vectibix)",
                "Regorafenib (Stivarga)",
                "Trifluridine/Tipiracil (Lonsurf)",
                "Pembrolizumab (Keytruda)",
                "Nivolumab (Opdivo)",
                "Ipilimumab (Yervoy)",
                "Ramucirumab (Cyramza)",
                "Aflibercept (Zaltrap)",
                "Encorafenib (Braftovi)",
                "Binimetinib (Mektovi)",
                "Trastuzumab (Herceptin)",
                "Pertuzumab (Perjeta)",
                "Lapatinib (Tykerb)",
                "Neratinib (Nerlynx)",
                "Ado-Trastuzumab Emtansine (Kadcyla)",
                "Fam-Trastuzumab Deruxtecan (Enhertu)",
                "Margetuximab (Margenza)",
                "Tucatinib (Tukysa)",
                "Sacituzumab Govitecan (Trodelvy)"
            ]
        }
    ],
    "anthropic.claude-3-haiku-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "anthropic.claude-3-haiku-v1:0",
            "response": [
                "Aspirin (ASA)",
                "Bevacizumab (BEV)",
                "Capecitabine (CAP)",
                "Cetuximab (CET)",
                "Encorafenib (ENC)",
                "Fluorouracil (FLU)",
                "Irinotecan (IRI)",
                "Lenvatinib (LEN)",
                "Nivolumab (NIV)",
                "Oxaliplatin (OXA)",
                "Panitumumab (PAN)",
                "Pembrolizumab (PEM)",
                "Ramucirumab (RAM)",
                "Regorafenib (REG)",
                "Sorafenib (SOR)",
                "Trifluridine/Tipiracil (TRI)",
                "Trametinib (TRA)",
                "Trastuzumab (TRA)",
                "Vemurafenib (VEM)",
                "Ziv-Aflibercept (ZIV)"
            ]
        }
    ],
    "meta.llama3-8b-instruct-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "meta.llama3-8b-instruct-v1:0",
            "response": [
                "Avastin (Bevacizumab)",
                "Erlotinib",
                "Capecitabine",
                "Oxaliplatin",
                "FOLFIRI",
                "FOLFOX",
                "Panitumumab",
                "Cetuximab",
                "regorafenib",
                "BRAF inhibitors",
                "Vemurafenib",
                "Dabrafenib",
                "Trametinib",
                "Nivolumab",
                "Pembrolizumab",
                "Ramucirumab",
                "Bevacizumab + FOLFOX",
                "FOLFIRINOX",
                "Capox",
                "FOLFOXIRI",
                "Lenvatinib",
                "Aflibercept",
                "Ramucirumab + FOLFIRI",
                "regorafenib + cetuximab",
                "regorafenib + bevacizumab",
                "Nivolumab + ipilimumab"
            ]
        }
    ],
    "meta.llama3-70b-instruct-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "meta.llama3-70b-instruct-v1:0",
            "response": [
                "Capecitabine (Xeloda)",
                "Oxaliplatin (Eloxatin)",
                "Irinotecan (Camptosar)",
                "5-Fluorouracil (5-FU)",
                "Levamisole",
                "Bevacizumab (Avastin)",
                "Cetuximab (Erbitux)",
                "Panitumumab (Vectibix)",
                "Ramucirumab (Cyramza)",
                "Aflibercept (Zaltrap)",
                "Regorafenib (Stivarga)",
                "Trifluridine/tipiracil (Lonsurf)",
                "Encorafenib (Braftovi)",
                "Binimetinib (Mektovi)",
                "Cemiplimab (Libtayo)",
                "Nivolumab (Opdivo)",
                "Ipilimumab (Yervoy)",
                "Ramucirumab (Cyramza)",
                "Pembrolizumab (Keytruda)",
                "Atezolizumab (Tecentriq)",
                "Durvalumab (Imfinzi)",
                "Tremelimumab",
                "Sorafenib (Nexavar)",
                "Vemurafenib (Zelboraf)"
            ]
        }
    ],
    "amazon.titan-text-express-v1": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat colorectal cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for colorectal cancer"
            },
            "model": "amazon.titan-text-express-v1",
            "response": [
                {
                    "Referent": "5-fluorouracil (5-FU)",
                    "Canonical name": "5-Fluorouracil"
                },
                {
                    "Referent": "capecitabine (Xeloda)",
                    "Canonical name": "Capecitabine"
                },
                {
                    "Referent": "irinotecan (Camptosar)",
                    "Canonical name": "Irinotecan"
                },
                {
                    "Referent": "oxaliplatin (Eloxatin)",
                    "Canonical name": "Oxaliplatin"
                },
                {
                    "Referent": "bevacizumab (Avastin)",
                    "Canonical name": "Bevacizumab"
                },
                {
                    "Referent": "aflibercept (Zaltrap)",
                    "Canonical name": "Aflibercept"
                },
                {
                    "Referent": "regorafenib (Stivarga)",
                    "Canonical name": "Regorafenib"
                },
                {
                    "Referent": "panitumumab (Vectibix)",
                    "Canonical name": "Panitumumab"
                },
                {
                    "Referent": "cetuximab (Erbitux)",
                    "Canonical name": "Cetuximab"
                },
                {
                    "Referent": "ramucirumab (Cyramza)",
                    "Canonical name": "Ramucirumab"
                },
                {
                    "Referent": "trifluridine/tipiracil (Lonsurf)",
                    "Canonical name": "Trifluridine/tipiracil"
                },
                {
                    "Referent": "nivolumab (Opdivo)",
                    "Canonical name": "Nivolumab"
                },
                {
                    "Referent": "pembrolizumab (Keytruda)",
                    "Canonical name": "Pembrolizumab"
                },
                {
                    "Referent": "atezolizumab (Tecentriq)",
                    "Canonical name": "Atezolizumab"
                },
                {
                    "Referent": "durvalumab (Imfinzi)",
                    "Canonical name": "Durvalumab"
                },
                {
                    "Referent": "avelumab (Bavencio)",
                    "Canonical name": "Avelumab"
                },
                {
                    "Referent": "tremelimumab (Imjuvia)",
                    "Canonical name": "Tremelimumab"
                },
                {
                    "Referent": "ipilimumab (Yervoy)",
                    "Canonical name": "Ipilimumab"
                },
                {
                    "Referent": "nivolumab/ipilimumab (Opdivo/Yervoy)",
                    "Canonical name": "Nivolumab/ipilimumab"
                },
                {
                    "Referent": "dostarlimab (Jemperli)",
                    "Canonical name": "Dostarlimab"
                },
                {
                    "Referent": "tucatinib (Tukysa)",
                    "Canonical name": "Tucatinib"
                },
                {
                    "Referent": "enfuvirtide (Fuzeon)",
                    "Canonical name": "Enfuvirtide"
                },
                {
                    "Referent": "maraviroc (Selzentry)",
                    "Canonical name": "Maraviroc"
                },
                {
                    "Referent": "raltegravir (Isentress)",
                    "Canonical name": "Raltegravir"
                },
                {
                    "Referent": "elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (Biktarvy)",
                    "Canonical name": "Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide"
                },
                {
                    "Referent": "dolutegravir (Tivicay)",
                    "Canonical name": "Dolutegravir"
                },
                {
                    "Referent": "lamivudine/raltegravir (Epzicom)",
                    "Canonical name": "Lamivudine/raltegravir"
                },
                {
                    "Referent": "atazanavir/cobicistat (Evotaz)",
                    "Canonical name": "Atazanavir/cobicistat"
                },
                {
                    "Referent": "darunavir/cobicistat (Prezista)",
                    "Canonical name": "Darunavir/cobicistat"
                },
                {
                    "Referent": "lopinavir/ritonavir (Kaletra)",
                    "Canonical name": "Lopinavir/ritonavir"
                },
                {
                    "Referent": "elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (Stribild)",
                    "Canonical name": "Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate"
                },
                {
                    "Referent": "atazanavir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (Evotaz/Genvoya)",
                    "Canonical name": "Atazanavir/cobicistat/emtricitabine/tenofovir disoproxil fumarate"
                },
                {
                    "Referent": "dolutegravir/abacavir/lamivudine (Triumeq)",
                    "Canonical name": "Dolutegravir/abacavir/lamivudine"
                },
                {
                    "Referent": "lamivudine/abacavir/dolutegravir (Triumeq)",
                    "Canonical name": "Lamivudine/abacavir/dolutegravir"
                },
                {
                    "Referent": "dolutegravir/lamivudine (Dovato)",
                    "Canonical name": "Dolutegravir/lamivudine"
                },
                {
                    "Referent": "abacavir/dolutegravir/lamivudine (Triumeq)",
                    "Canonical name": "Abacavir/dolutegravir/lamivudine"
                }
            ]
        }
    ]
}